Skip to Main Content

Author Details

Mark Bettington
University of Queensland
2012
48
22
PMIDPaper TitleJournal TitlePublished Year
37366086Pathological features associated with metastasis in patients with early invasive (pT1) colorectal carcinoma in colorectal polyps.Histopathology2023
37366086Pathological features associated with metastasis in patients with early invasive (pT1) colorectal carcinoma in colorectal polyps.Histopathology2023
34230216<i>Braf</i> mutation induces rapid neoplastic transformation in the aged and aberrantly methylated intestinal epithelium.Gut2022
35916436Could it be groove pancreatitis? A frequently misdiagnosed condition with a surgical solution.ANZ J Surg2022
34230216<i>Braf</i> mutation induces rapid neoplastic transformation in the aged and aberrantly methylated intestinal epithelium.Gut2022
34883119The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis.Gastroenterology2022
35916436Could it be groove pancreatitis? A frequently misdiagnosed condition with a surgical solution.ANZ J Surg2022
34883119The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis.Gastroenterology2022
33382496The role of histopathology in the diagnosis and management of coeliac disease and other malabsorptive conditions.Histopathology2021
33632927Association of <i>Fusobacterium nucleatum</i> with Specific T-cell Subsets in the Colorectal Carcinoma Microenvironment.Clin Cancer Res2021
34103499A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses.Nat Commun2021
33369858Diagnostic and therapeutic considerations in biopsy-proven type 2 autoimmune pancreatitis: comparative analysis with biopsy-proven type 1 autoimmune pancreatitis.ANZ J Surg2021
33382496The role of histopathology in the diagnosis and management of coeliac disease and other malabsorptive conditions.Histopathology2021
33632927Association of <i>Fusobacterium nucleatum</i> with Specific T-cell Subsets in the Colorectal Carcinoma Microenvironment.Clin Cancer Res2021
34103499A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses.Nat Commun2021
33369858Diagnostic and therapeutic considerations in biopsy-proven type 2 autoimmune pancreatitis: comparative analysis with biopsy-proven type 1 autoimmune pancreatitis.ANZ J Surg2021
32939056Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1.Br J Cancer2020
31917154Traditional serrated adenoma-like lesions in patients with inflammatory bowel disease.Hum Pathol2020
32939056Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1.Br J Cancer2020
31917154Traditional serrated adenoma-like lesions in patients with inflammatory bowel disease.Hum Pathol2020
29570172Sessile Serrated Adenomas in Young Patients may have Limited Risk of Malignant Progression.J Clin Gastroenterol2019
30350370Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications.J Pathol2019
29570172Sessile Serrated Adenomas in Young Patients may have Limited Risk of Malignant Progression.J Clin Gastroenterol2019
29666172Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis.Gut2019
31028362An update on the morphology and molecular pathology of serrated colorectal polyps and associated carcinomas.Mod Pathol2019
30894377CD96 Is an Immune Checkpoint That Regulates CD8<sup>+</sup> T-cell Antitumor Function.Cancer Immunol Res2019
31200767DNA methylation changes that precede onset of dysplasia in advanced sessile serrated adenomas.Clin Epigenetics2019
30825335BRAF V600E immunohistochemistry demonstrates that some sessile serrated lesions with adenomatous dysplasia may represent collision lesions.Histopathology2019
31200767DNA methylation changes that precede onset of dysplasia in advanced sessile serrated adenomas.Clin Epigenetics2019
30894377CD96 Is an Immune Checkpoint That Regulates CD8<sup>+</sup> T-cell Antitumor Function.Cancer Immunol Res2019
30825335BRAF V600E immunohistochemistry demonstrates that some sessile serrated lesions with adenomatous dysplasia may represent collision lesions.Histopathology2019
31028362An update on the morphology and molecular pathology of serrated colorectal polyps and associated carcinomas.Mod Pathol2019
30350370Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications.J Pathol2019
29666172Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis.Gut2019
29235923Oncogenic BRAF mutation induces DNA methylation changes in a murine model for human serrated colorectal neoplasia.Epigenetics2018
30009818CpG Island Methylation in Sessile Serrated Adenomas Increases With Age, Indicating Lower Risk of Malignancy in Young Patients.Gastroenterology2018
30007084A morphological and molecular study of proposed early forms of traditional serrated adenoma.Histopathology2018
29304767MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF<sup>V600E</sup> mutation.BMC Cancer2018
29235923Oncogenic BRAF mutation induces DNA methylation changes in a murine model for human serrated colorectal neoplasia.Epigenetics2018
29148535The role of APC in WNT pathway activation in serrated neoplasia.Mod Pathol2018
30009818CpG Island Methylation in Sessile Serrated Adenomas Increases With Age, Indicating Lower Risk of Malignancy in Young Patients.Gastroenterology2018
30007084A morphological and molecular study of proposed early forms of traditional serrated adenoma.Histopathology2018
29304767MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF<sup>V600E</sup> mutation.BMC Cancer2018
29148535The role of APC in WNT pathway activation in serrated neoplasia.Mod Pathol2018
27913047Doxycycline induced oesophagitis: five cases highlighting a distinctive pattern of injury.Pathology2017
28424866Histopathological findings of extra-ileal manifestations at initial diagnosis of Crohn's disease-related ileitis.Virchows Arch2017
28752838Sessile serrated adenomas with dysplasia: morphological patterns and correlations with MLH1 immunohistochemistry.Mod Pathol2017
26475632Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma.Gut2017
27860102High prevalence of sessile serrated adenomas in contemporary outpatient colonoscopy practice.Intern Med J2017
28164369GNAS mutations are present in colorectal traditional serrated adenomas, serrated tubulovillous adenomas and serrated adenocarcinomas with adverse prognostic features.Histopathology2017
  • 1 - 50 of 96

Recommended Authors

Erika Hissong
New York-Presbyterian Hospital/Weill Cornell Medicine
Career Start Year 2015
Number of shared co-authors 0
Daniela Hirsch
Institute of Pathology, University Medical Center Mannheim, University of Heidelberg
Career Start Year 2012
Number of shared co-authors 2
Meike de Wit
The Netherlands Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
Trilokesh D Kidambi
City of Hope National Medical Center
Career Start Year 2010
Number of shared co-authors 0
Ann Tipps
University of California San Diego
Career Start Year 2010
Number of shared co-authors 0
Sarah K McGill
University of North Carolina School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Bita V Naini
university of california los angeles Medical Center
Career Start Year 2008
Number of shared co-authors 1
Daniel L Edelstein
Sysmex Inostics Inc.
Career Start Year 2006
Number of shared co-authors 0
Matthew B Yurgelun
34Dana-Farber/Brigham and Women's Cancer Center.
Career Start Year 2005
Number of shared co-authors 5
Eduardo Vilar
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 2
Elena M Stoffel
Rogel Cancer Center, University of Michigan ann arbor
Career Start Year 2002
Number of shared co-authors 3
Blaise A Clarke
University of Toronto.
Career Start Year 2001
Number of shared co-authors 6
Ajay Bansal
Regeneron Pharmaceuticals Inc.
Career Start Year 2000
Number of shared co-authors 0
Abbas Agaimy
Institute of Pathology, Friedrich-Alexander University Erlangen-Nurnberg (FAU)
Career Start Year 2000
Number of shared co-authors 3
Pelvender Gill
University of Oxford
Career Start Year 2000
Number of shared co-authors 0
Arief A Suriawinata
Dartmouth Hitchcock Medical Center
Career Start Year 1999
Number of shared co-authors 0
Sharad C Mathur
Kansas City VA Medical Center
Career Start Year 1998
Number of shared co-authors 0
William M Grady
. Fred Hutchinson Cancer Center
Career Start Year 1997
Number of shared co-authors 9
Robert Gryfe
University of Toronto
Career Start Year 1997
Number of shared co-authors 2
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 0
Remond J A Fijneman
The Netherlands Cancer Institute
Career Start Year 1993
Number of shared co-authors 0
Mee-Yon Cho
Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine
Career Start Year 1993
Number of shared co-authors 0
Gerrit A Meijer
The Netherlands Cancer Institute
Career Start Year 1992
Number of shared co-authors 1
Michael Vieth
Institute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg
Career Start Year 1991
Number of shared co-authors 3
Nicholas J Hawkins
School of Public Health, Imperial College London
Career Start Year 1990
Number of shared co-authors 5
Aaron Pollett
Mount Sinai Hospital
Career Start Year 1990
Number of shared co-authors 4
Robyn L Ward
University of Sydney
Career Start Year 1989
Number of shared co-authors 15
Juan P Palazzo
Thomas Jefferson University Hospital
Career Start Year 1988
Number of shared co-authors 3
Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Career Start Year 1983
Number of shared co-authors 30
Hoguen Kim
Korea Advanced Institute of Science and Technology (KAIST)
Career Start Year 1982
Number of shared co-authors 0

Collaborators

Andrew D Clouston
University of Queensland
Co-authored papers 6
Sunil R Lakhani
University of Queensland
Co-authored papers 4
Tamsin R M Lannagan
Adelaide Medical School, University of Adelaide
Co-authored papers 4
Susan L Woods
Adelaide Medical School, University of Adelaide
Co-authored papers 4
Daniel L Worthley
South Australian Health and Medical Research Institute
Co-authored papers 4
Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
Co-authored papers 3
Jason S Lee
QIMR Berghofer Medical Research Institute
Co-authored papers 2
John V Pearson
QIMR Berghofer Medical Research Institute
Co-authored papers 2
Grant W Montgomery
Co-authored papers 2
Katia Nones
QIMR Berghofer Medical Research Institute
Co-authored papers 2
Nicola Waddell
QIMR Berghofer Medical Research Institute
Co-authored papers 2
Haran Sivakumaran
QIMR Berghofer Medical Research Institute
Co-authored papers 1
F??tima Carneiro
Centro Hospitalar Universitario de Sao Joao.
Co-authored papers 1
Noralane M Lindor
Mayo Clinic
Co-authored papers 1
Peter J Hulick
Neaman Center for Personalized Medicine, NorthShore University HealthSystem
Co-authored papers 1
Jone E Sampson
Oregon Health & Science University
Co-authored papers 1
Xiaoqing Chen
QIMR Berghofer Medical Research Institute
Co-authored papers 1
David E Goldgar
University of Utah
Co-authored papers 1
Jacqueline Armstrong
SA Pathology at the Women's and Children's Hospital
Co-authored papers 1
Stacey L Edwards
QIMR Berghofer Medical Research Institute
Co-authored papers 1
Susan Bullman
Fred Hutchinson Cancer Center
Co-authored papers 1
Jonathan Beesley
QIMR Berghofer Medical Research Institute
Co-authored papers 1
Amanda B Spurdle
QIMR Berghofer Medical Research Institute
Co-authored papers 1
Theo Heller
National Institute of Diabetes and Digestive and Kidney Diseases
Co-authored papers 1
Alireza Heravi-Moussavi
Ferdowsi University of Mashhad
Co-authored papers 1
Pavel N Pichurin
Mayo Clinic
Co-authored papers 1
Akihiro Sakai
Tokai University
Co-authored papers 1
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Juliet D French
QIMR Berghofer Medical Research Institute
Co-authored papers 1
Lachlan J M Coin
The Peter Doherty Institute for Infection and Immunity, The University of Melbourne
Co-authored papers 1
Release 1.2